Loris Bernard
YOU?
Author Swipe
View article: PIK3CA mutation analysis in circulating tumor cells of patients with hormone receptor positive metastatic breast cancer
PIK3CA mutation analysis in circulating tumor cells of patients with hormone receptor positive metastatic breast cancer Open
View article: <i>CDH1</i> Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype
<i>CDH1</i> Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype Open
Importance Pathogenic or likely pathogenic (P/LP) germline CDH1 variants are associated with risk for diffuse gastric cancer and lobular breast cancer (LBC) in the so-called hereditary diffuse gastric cancer (HDGC) syndrome. However, in so…
View article: Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene
Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene Open
View article: Supplementary Table Legend from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Supplementary Table Legend from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium Open
PDF file, 45K.
View article: Supplementary Table 2 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Supplementary Table 2 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium Open
PDF file, 70K, Availability of information on tumor morphology and receptor status for Europeans, by each included BCAC study.
View article: Data from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Data from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium Open
Background: Our recent genome-wide association study identified a novel breast cancer susceptibility locus at 9q31.2 (rs865686).Methods: To further investigate the rs865686–breast cancer association, we conducted a replicatio…
View article: Data from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Data from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium Open
Background: Our recent genome-wide association study identified a novel breast cancer susceptibility locus at 9q31.2 (rs865686).Methods: To further investigate the rs865686–breast cancer association, we conducted a replicatio…
View article: Supplementary Table Legend from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Supplementary Table Legend from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium Open
PDF file, 45K.
View article: Supplementary Table 1 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Supplementary Table 1 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium Open
PDF file, 107K, Summary characteristics of the participating BCAC case-control studies.
View article: Supplementary Table 3 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Supplementary Table 3 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium Open
PDF file, 57K, Genotyping characteristics of each BCAC participating study.
View article: Supplementary Table 3 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Supplementary Table 3 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium Open
PDF file, 57K, Genotyping characteristics of each BCAC participating study.
View article: Supplementary Table 2 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Supplementary Table 2 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium Open
PDF file, 70K, Availability of information on tumor morphology and receptor status for Europeans, by each included BCAC study.
View article: Supplementary Table 1 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Supplementary Table 1 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium Open
PDF file, 107K, Summary characteristics of the participating BCAC case-control studies.
View article: Germline pathogenic variants in metaplastic breast cancer patients: a monocentric study and literature review
Germline pathogenic variants in metaplastic breast cancer patients: a monocentric study and literature review Open
Metaplastic breast cancer (MpBC) is a rare, aggressive type of breast cancer, often classified as triple negative (TN). Scarce information is available about germline testing in MpBC. We retrospectively reviewed MpBC patients counseled at …
View article: Additional file 3 of Exploring the link between MORF4L1 and risk of breast cancer
Additional file 3 of Exploring the link between MORF4L1 and risk of breast cancer Open
Additional file 3: Primers for sequencing of MORF4L1. Supplementary Table 3 containing details of primers used for sequencing of MORF4L1. (XLS 20 KB)
View article: Additional file 4 of Exploring the link between MORF4L1 and risk of breast cancer
Additional file 4 of Exploring the link between MORF4L1 and risk of breast cancer Open
Additional file 4: FA/BrCa signaling pathway components. Supplementary Table 4 containing details of known and potential FA/BrCa signaling pathway components identified through Y2H screens. (XLS 32 KB)
View article: Additional file 2 of Exploring the link between MORF4L1 and risk of breast cancer
Additional file 2 of Exploring the link between MORF4L1 and risk of breast cancer Open
Additional file 2: siRNAs used in the present study. Supplementary Table 2 containing details of the siRNAs used in the present study. (XLS 22 KB)
View article: Additional file of Exploring the link between MORF4L1 and risk of breast cancer
Additional file of Exploring the link between MORF4L1 and risk of breast cancer Open
Additional file of Exploring the link between MORF4L1 and risk of breast cancer
View article: Additional file of Exploring the link between MORF4L1 and risk of breast cancer
Additional file of Exploring the link between MORF4L1 and risk of breast cancer Open
Additional file of Exploring the link between MORF4L1 and risk of breast cancer
View article: Additional file 13 of Exploring the link between MORF4L1 and risk of breast cancer
Additional file 13 of Exploring the link between MORF4L1 and risk of breast cancer Open
Additional file 13: BrCa risk estimates for rs7164529 and rs10519219. Supplementary Table 5 containing BrCa risk estimates (HR and wHR) for rs7164529 (additive model) and rs10519219 (recessive model) among BRCA2 mutation carriers across pa…
View article: Additional file of Exploring the link between MORF4L1 and risk of breast cancer
Additional file of Exploring the link between MORF4L1 and risk of breast cancer Open
Additional file of Exploring the link between MORF4L1 and risk of breast cancer
View article: Additional file of Exploring the link between MORF4L1 and risk of breast cancer
Additional file of Exploring the link between MORF4L1 and risk of breast cancer Open
Additional file of Exploring the link between MORF4L1 and risk of breast cancer
View article: Additional file of Exploring the link between MORF4L1 and risk of breast cancer
Additional file of Exploring the link between MORF4L1 and risk of breast cancer Open
Additional file of Exploring the link between MORF4L1 and risk of breast cancer
View article: Additional file 1 of Exploring the link between MORF4L1 and risk of breast cancer
Additional file 1 of Exploring the link between MORF4L1 and risk of breast cancer Open
Additional file 1: Y2H baits for 12 proteins in the FA/BrCa signaling pathway. Supplementary Table 1 containing details of the design of Y2H baits for 12 proteins in the FA/BrCa signaling pathway. (XLS 28 KB)
View article: Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy
Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy Open
The PARP inhibitor olaparib has been approved in the maintenance setting of platinum-sensitive epithelial ovarian cancer patients with germline or somatic BRCA1/2 mutation. Therefore, the availability of a tumor BRCA test has become a clin…
View article: A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data
A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data Open
Background The landscape of cancer-predisposing genes has been extensively investigated in the last 30 years with various methodologies ranging from candidate gene to genome-wide association studies. However, sequencing data are still poor…
View article: Additional file 2: Table S1-5. of A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data
Additional file 2: Table S1-5. of A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data Open
with reference set of genes and SNPs used in this work. (XLSX 102 kb)
View article: Additional file 3: Table S6-10. of A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data
Additional file 3: Table S6-10. of A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data Open
with results from SNPs in breast cancer-associated blocks, SNPs overlapping with somatic mutations and tested for truncations in candidate tumor suppressor genes. (XLSX 157 kb)
View article: Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer Open
Breast and ovarian cancer risks varied by type and location of BRCA1/2 mutations. With appropriate validation, these data may have implications for risk assessment and cancer prevention decision making for carriers of BRCA1 and BRCA2 mutat…
View article: Identification of six new susceptibility loci for invasive epithelial ovarian cancer
Identification of six new susceptibility loci for invasive epithelial ovarian cancer Open